Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.49 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GNRHR | P30968 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6839755 | 0.89 | BAZ2B (0.47) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL11821334 | 0.82 | BAZ2B (0.48) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7118717 | 0.81 | KCNH2 (0.60) | BAZ2BBAZ2AKDM4EALDH1A1LMNA | |
| SCHEMBL6279964 | 0.77 | BAZ2B (0.50) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7111537 | 0.74 | BAZ2B (0.47) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL11582138 | 0.71 | ALDH1A1 (0.60) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL10084828 | 0.70 | LMNA (0.58) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL9835705 | 0.70 | BAZ2B (0.54) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL6050613 | 0.70 | BAZ2B (0.54) | BAZ2BBAZ2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL9383778 | 0.69 | KMT2A (0.67) | BAZ2BBAZ2AKDM4EALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110787-A1 | Heteroaryl-ethanolamine derivatives as antiviral agents | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110787-A1 | Heteroaryl-ethanolamine derivatives as antiviral agents | RPL35, ZC3HAV1, RPL5 | BAZ2B 397/4885BAZ2A 259/4885KDM4E 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.